Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics
TORONTO, ON and HAMBURG, GERMANY--(Marketwired - January 17, 2017) - Evotec AG (FRANKFURT: EVT) (TecDAX, ISIN: DE0005664809) and MaRS Innovation today announced the launch of Fibrocor Therapeutics LP ("Fibrocor"), a Toronto-based company focused …